-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
-
US slams China policies on chips but will delay tariffs to 2027
-
Arsenal reach League Cup semis with shoot-out win over Palace
-
Contenders Senegal, Nigeria start Cup of Nations campaigns with wins
-
Tunisia ease past Uganda to win Cup of Nations opener
-
S&P 500 surges to record after strong US economic report
-
UK police say no action against Bob Vylan duo over Israel army chant
-
Libya's top military chief killed in plane crash in Turkey
-
Venezuela passes law to jail backers of US oil blockade
-
French parliament passes emergency budget extension
Trump-backed panel sows doubt over Covid-19 shots
A Trump-backed health panel questioned Friday the efficacy and safety of Covid-19 vaccines -- and declined explicitly to recommend them -- in an argument some experts said center on "myths" and "anecdotes."
The Advisory Committee on Immunization Practices (ACIP) -- a panel stacked with members handpicked by controversial US health secretary and anti-vaccination advocate Robert F. Kennedy Jr -- said obtaining a Covid-19 shot should be based on individual choice in consultation with a medical professional.
The panel also approved language recommending that the Centers for Disease Control and Prevention urge health care providers to more strongly warn about alleged risks from vaccinations.
Many medical and scientific organizations have cited evidence of the Covid shot's safety and its record of providing strong protection against severe illness or death.
Calling the committee's actions "extraordinarily vague," Sean O'Leary of the American Academy of Pediatrics said "this was like nothing I've ever seen."
"What it looked like to me was a lot of clear efforts to sow distrust in vaccines, to instill fear," he told AFP.
"The focus of a lot of the discussion that we saw today around Covid vaccines was around myths, anecdotes, case series, case reports," O'Leary said. "They were not focused at all on the actual science."
Those comments mirrored criticisms leveled by non-voting observers who attended the meeting.
"It's troubling to see the erosion of the committee's integrity," said Sandra Fryhofer of the American Medical Association.
President Donald Trump's Food and Drug Administration has already narrowed approval for Covid shots -- which all Americans could once get with relative ease -- to the elderly and people with underlying conditions.
That followed Kennedy's spring announcement that the United States would no longer recommend the shots for children and healthy pregnant women.
Public health experts have warned these shifts could muddle access for people seeking boosters both in terms of cost and availability, amid a resurgence in cases and hospitalizations.
The ACIP committee considered whether to require that any person seeking a Covid vaccine first obtain a prescription -- but that measure narrowly failed by a tiebreak vote.
"The segment of the population that is under-insured, has lack of access to health care -- they're going to be unable to get a prescription. And those are the people that are at highest risk," said ACIP member and epidemiologist Catherine Stein in her dissent.
- Confusion -
The ACIP meeting's first day ended in confusion and contradiction. The committee recommended no child under four should receive the combination MMRV shot, which covers measles, mumps, rubella and varicella.
But they also declared that a federal children's vaccine program should still pay for it -- and in a chaotic twist, they reversed that decision in a second vote Friday morning.
Parents will still be offered separate MMR and chicken pox injections for their children younger than four. The combination shot has a small risk of causing temporary, non-life-threatening febrile seizures.
Members also were meant to decide whether to recommend against the longstanding practice of immunizing newborns against Hepatitis B within the first 24 hours of life.
Public health experts have met the prospect of that move with widespread alarm.
Swift vaccination has proven the best way to prevent any maternal transmission of the incurable, highly contagious disease that can cause severe liver damage and cancer later in life, said Adam Langer, a CDC scientist who presented to the voting members.
Ultimately the committee decided more debate was needed.
Many respected members of medical institutions have criticized the redesigned ACIP panel.
"What we're seeing is what happens when individuals who have don't have a basic understanding about how vaccines are delivered are making these crucial policy decisions for the American public," O'Leary said.
P.Santos--AMWN